Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,9412,960 of 20,252 grants

Active NON-SBIR/STTR RPGS
Understanding the impact of chemotherapy on breast cancer metastasis and immune function in the liver
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Project Summary Despite treatment with neoadjuvant chemotherapy, 30-40% of patients diagnosed with early-stage triple- negative breast cancer (TNBC) develop metastasis and die of t...

$4.73M
USD
Active NON-SBIR/STTR RPGS
Matricellular proteins of the CNN family as regulators of tumor-induced cachexia
NATIONAL CANCER INSTITUTE University of Florida United States 2023 – 2028

Summary/Abstract Cancer-associated cachexia is a multifactorial syndrome characterized by the involuntary loss of body and skeletal muscle mass (with or without fat loss) that redu...

$4.59M
USD
Active NON-SBIR/STTR RPGS
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

SUMMARY/ABSTRACT While improvements in immune therapies have revolutionized treatments in some cancers, pediatric brain tumors are especially resistant to current immunotherapy tre...

$7.47M
USD
Active NON-SBIR/STTR RPGS
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2023 – 2028

Abstract: Bariatric surgery, currently the most effective treatment for morbid obesity, has become increasingly common in the US. Besides substantial and sustained weight loss, bar...

$6.89M
USD
Active NON-SBIR/STTR RPGS
Integrating multi-omics, imaging, and longitudinal data to predict radiation response in cervical cancer
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Cervical cancer is among the most common cancer diagnoses among women, and treatment failure of standard of care chemoradiation therapy (CRT) for locally a...

$4.82M
USD
Active NON-SBIR/STTR RPGS
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT The goal of this project is to dissect the immune evasion mechanisms and enable immunotherapy for children with high-risk Group 3 medulloblastoma (G3MB)...

$7.78M
USD
Completed OTHER RESEARCH-RELATED
Loss of Cell Identity as a Prerequisite for Breast Cancer Development
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2023 – 2024

ABSTRACT Transcription Factor (TF) networks are critical in suppressing cancer development by maintaining cell identity. TF networks are hierarchically organized, with pioneer TFs...

$1.95M
USD
Active NON-SBIR/STTR RPGS
Matricellular proteins of the CNN family as regulators of tumor-induced cachexia
NATIONAL CANCER INSTITUTE University of Florida United States 2023 – 2028

Summary/Abstract Cancer-associated cachexia is a multifactorial syndrome characterized by the involuntary loss of body and skeletal muscle mass (with or without fat loss) that redu...

$3.93M
USD
Active NON-SBIR/STTR RPGS
Understanding the impact of chemotherapy on breast cancer metastasis and immune function in the liver
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2028

Project Summary Despite treatment with neoadjuvant chemotherapy, 30-40% of patients diagnosed with early-stage triple- negative breast cancer (TNBC) develop metastasis and die of t...

$5.1M
USD
Active NON-SBIR/STTR RPGS
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT The goal of this project is to dissect the immune evasion mechanisms and enable immunotherapy for children with high-risk Group 3 medulloblastoma (G3MB)...

$8.19M
USD
Active NON-SBIR/STTR RPGS
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

SUMMARY/ABSTRACT While improvements in immune therapies have revolutionized treatments in some cancers, pediatric brain tumors are especially resistant to current immunotherapy tre...

$8.08M
USD
Completed NON-SBIR/STTR RPGS
A Scalable Continuous Production Platform for Large-Scale Manufacturing of Therapeutic Exosomes
NATIONAL CANCER INSTITUTE University of Notre Dame United States 2023 – 2025

Project Summary Exosomes are a subset of extracellular vesicles, with diameters between 30 and 200 nm, secreted by most eukaryotic cells. They deliver bioactive cargos, such as lip...

$4.02M
USD
Completed NON-SBIR/STTR RPGS
Deep Learning of Mass Spectrometry Imaging
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2023 – 2025

PROJECT SUMMARY Mass spectrometry imaging (MSI) is a rapidly developing technology which gives pathologists many new types of targets (e.g., metabolites and lipids) to assess for t...

$4.36M
USD
Active NON-SBIR/STTR RPGS
Integrating multi-omics, imaging, and longitudinal data to predict radiation response in cervical cancer
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Cervical cancer is among the most common cancer diagnoses among women, and treatment failure of standard of care chemoradiation therapy (CRT) for locally a...

$5.21M
USD
Active OTHER RESEARCH-RELATED
Catalyzing Cancer Research among Urban Underrepresented Minority Youths and Teachers (CATALYST)
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2023 – 2028

Project Summary West Baltimore is comprised of majority minority communities that are among the most economically and academically disadvantaged in the US and are disproprotionatel...

$3.89M
USD
Active OTHER RESEARCH-RELATED
Catalyzing Cancer Research among Urban Underrepresented Minority Youths and Teachers (CATALYST)
NATIONAL CANCER INSTITUTE University of Maryland Baltimore United States 2023 – 2028

Project Summary West Baltimore is comprised of majority minority communities that are among the most economically and academically disadvantaged in the US and are disproprotionatel...

$4.1M
USD
Active NON-SBIR/STTR RPGS
Epigallocatechin gallate for prevention of lethal cirrhosis complications
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Summary Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis, and the fastest rising cancer mortality in the U.S. Due to the limited efficacy of...

$5.86M
USD
Active NON-SBIR/STTR RPGS
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY Bladder cancer is one of the top 10 most frequent cancers, yet the most underfunded cancer by NCI based on funding dollars and ratio of funding/mortality. There has...

$3.42M
USD
Active NON-SBIR/STTR RPGS
Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2026

ABSTRACT Women living in low- and middle-income countries (LMICs) face a disproportionate burden of incidence and mortality from cervical cancer, accounting for 85% of incident cas...

$2.78M
USD
Active NON-SBIR/STTR RPGS
Neurotrophic strategy to mitigate chemotherapy-related brain injury
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

ABSTRACT Cancer-related cognitive impairment (CRCI), often referred as “chemobrain”, is prevalent up to 75% of all breast cancer survivors. These impairments cause significant dist...

$4.77M
USD